To appear in Best of the Brokers, email your research to notes@cityam.com

ALLIANCE PHARMA

P 70 58.40 65 21 Mar 60 55 15 Mar 16 Mar 20 Mar 17 Mar 21 Mar

Analysts at Peel Hunt said that Alliance Pharma, the international healthcare business, FY22 results are "exactly in line with its trading update in January". Underlying profit before tax was £30.3m down from £42.2m in FY21. Despite the loss, analysts said that the outlook for FY23 is positive as the company expects Kelo-cote growth above 20 per cent. "We think today's results are an incremental positive," analysts said. The analyst rated it a "hold".

HENRY BOOT

P 235 225 230 21 Mar 225 220 215 15 Mar 16 Mar 20 Mar 17 Mar 21 Mar

Analysts at Peel Hunt said that construction firm Henry Boot delivered a "record underlying profit" of £56.1m in FY22, well ahead of last year's £29.3m. However, due to the housing market current climate said that they remain "cautious" about the company for the year. "The timing of some of the group's lumpier projects is likely to remain uncertain, and estimates for the year are likely to reduce by c.£4m, to £38m," analysts said. The analyst rated it a "buy".

(c) 2023 City A.M., source Newspaper